| Date | Title | Description |
| 30.12.2024 | Buffalo Spree Names Record 143 Roswell Park Physicians as Top Doctors for 2025 | Buffalo Spree Top Doctors 2025
As the year comes to a close, Roswell Park Comprehensive Cancer Center honors the 143 physicians across 35 specialties named to Buffalo Spree magazine's Top Doctors list for 2025. The annual list is compiled t... |
| 19.12.2024 | New Frontiers in Cancer Detection and Treatment: A Dual Approach to Combat Deadly Diseases | In the relentless battle against cancer, two recent breakthroughs shine a light on the path forward. Pharus Diagnostics LLC has unveiled a groundbreaking test for early pancreatic cancer detection, while researchers at Roswell Park Comprehe... |
| 18.12.2024 | Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer | Dhyan Chandra, PhD, Professor of Oncology in the Department of Pharmacology & Therapeutics at Roswell Park
A team of researchers at Roswell Park, led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine pros... |
| 16.12.2024 | Governor Hochul Celebrates the Opening Of New York's First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center in Buffalo | Pictured left to right: Candace Johnson, PhD, President, CEO, and M&T Bank Presidential Chair in Leadership at Roswell Park; Governor Kathy Hochul; and Roswell Park patient Chris Vogelsang.
Governor Kathy Hochul today celebrated the ope... |
| 12.12.2024 | Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer | Emese Zsiros, MD, PhD, FACOG
A study led by Roswell Park provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian can... |
| 10.12.2024 | Could Venetoclax Improve Outcomes of CAR T for Patients with Resistant B-Cell Lymphomas? New Insights at ASH | Francisco Hernandez-Ilizaliturri, MD, Professor of Oncology and Director of Lymphoma Research in Roswell Park’s Department of Medicine
About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, wi... |
| 09.12.2024 | Strength in Numbers: How Resistance Training Transforms Lives for Multiple Myeloma Patients | In the battle against cancer, every weapon counts. For patients with multiple myeloma, a type of blood cancer, a new ally has emerged: resistance training. Researchers at Roswell Park Comprehensive Cancer Center have unveiled groundbreaking... |
| 09.12.2024 | Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team Shows | Jens Hillengass, MD, PhD and Janine Joseph, MS, MBA
Researchers from Roswell Park Comprehensive Cancer Center will present compelling findings showcasing significant benefits of resistance training for patients with multiple myeloma, in a t... |
| 08.12.2024 | Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma | Kara Kelly, MD, and Matthew Cortese, MD, MPH
The results of two important lymphoma studies led by experts at Roswell Park will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of Hem... |
| 07.12.2024 | Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia | Matthew Cortese, MD, MPH, Assistant Professor of Oncology in Roswell Park’s departments of Medicine and Cancer Genetics & Genomics
Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax (brand... |
| 04.12.2024 | Tomorrow's Promise, Today's Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment | From left to right, Candace S. Johnson, PhD, Cameron Nolan, Roswell Park nurse , and Michael Wong, MD, PhD, FRPC,
Roswell Park President and CEO Candace S. Johnson, PhD, today introduced the cancer center's first Physician in Chief — and th... |
| 26.11.2024 | Metformin: A Dual Weapon Against Diabetes and Lung Cancer? | In the world of medicine, the unexpected often becomes the norm. A diabetes drug, metformin, has emerged as a potential ally in the fight against lung cancer, particularly for those battling obesity. This revelation, stemming from a recent ... |
| 26.11.2024 | Diabetes Drug Appears to Fight Lung Cancer -- But Only in Overweight or Obese Patients | Sai Yendamuri, MD, MBA, FACS, Chief Strategy Officer and Chair of Thoracic Surgery at Roswell Park Comprehensive Cancer Center
Retrospective study led by Roswell Park's Dr. Sai Yendamuri provides long-sought evidence
Metformin seems to stre... |
| 26.11.2024 | Roswell Park Launches First-of-Its-Kind Oncology Training Program for Nurse-Scientists With $2M NCI Grant | Roswell Park/University at Buffalo Oncology Nurse Scientist Training Program
Program provides specialized training for nurses with advanced degrees, driving innovation in cancer research, care
Collaboration with UB School of Nursing equips ... |
| 18.11.2024 | Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer | Roswell Park logo
High rate of complete remission achieved without immune-related adverse side effects in patients with TNBC
Triple-negative breast cancer accounts for 10-20% of all breast cancers
Study assessed a new pre-surgery immunother... |
| 29.10.2024 | New Computational Method Links One Mammal's Striking Longevity and Resistance to Cancer With 'Dark Genome' | Roswell Park logo
Study reveals remarkable evolutionary stability of the naked mole-rat's genome, and implications for drug development
BUFFALO, N.Y., Oct. 29, 2024 /PRNewswire-PRWeb/ --
Roswell Park-led team develops new method for measuri... |
| 16.10.2024 | The Pulse of Physician Well-Being: A New Era in Healthcare | In the heart of healthcare, a quiet revolution is taking place. Hospitals and health systems across the United States are waking up to a pressing reality: physician well-being is not just a luxury; it’s a necessity. As burnout rates have so... |
| 15.10.2024 | Staff Resiliency Initiatives Earn Roswell Park AMA 'Joy in Medicine' Recognition | Roswell Park Residents 2024
Buffalo cancer center honored by the AMA's Joy in Medicine Health System Recognition Program
Biannual surveys and listening campaigns enhance physician well-being
Roswell Park awarded recognition by AMA's Joy in ... |
| 01.10.2024 | Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia | “Roswell Park leukemia patients were among the first in the entire world to receive treatment with this menin inhibitor,” says Roswell Park Leukemia Chief Eunice Wang, MD.
The Clinical Leukemia Service at Roswell Park Comprehensive Cancer C... |
| 20.09.2024 | Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals | Roswell Park’s Theresa Hahn, PhD, led a new analysis that looked at trends in bone marrow transplant among patients of different ages, races and ethnicities.
Historically, some patients with blood cancers have been less likely than others t... |
| 19.09.2024 | A New Dawn in Kidney Cancer Treatment: Roswell Park's Breakthrough Regimen | In the realm of cancer treatment, hope often flickers like a candle in the dark. But recent findings from Roswell Park Comprehensive Cancer Center have ignited a brighter flame for patients battling metastatic kidney cancer. At the European... |
| 15.09.2024 | Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer | Roswell Park's Saby George, MD, presented study findings highlighting a treatment combination shown to extend survival in patients with advanced kidney cancer.
During the European Society for Medical Oncology (ESMO) Congress, Saby George, M... |
| 02.09.2024 | BRMC, OGH ‘Pulse of the Community Gala’ set for Sept. 20 | ELLICOTTVILLE — Kaleida Health facilities Bradford Regional Medical Center (BRMC) and Olean General Hospital will host the 2nd annual Pulse of the Community Gala on Friday, Sept. 20.
The event is presented by the Bradford Hospital Foundatio... |
| 12.08.2024 | Roswell Park Indigenous Cancer Screening/Navigation Success Reaches New Mexico with BMS Foundation Grant | The Indigenous Cancer Health team at Roswell Park Comprehensive Cancer Center in Buffalo, NY.
A three-year, $689,000 grant from the Bristol Myers Squibb Foundation will enable Roswell Park's Department of Indigenous Cancer Health and the Un... |
| 06.08.2024 | Phase 2 Clinical Trial Clarifies Role of JAK2 Inhibitor in Combating Acute Graft-Versus-Host Disease | Roswell Park’s Brian Betts, MD, led new research showing that adding a JAK inhibitor to standard treatment did not improve GVHD prevention for patients with hematologic cancers.
The results of a phase 2 trial led by Roswell Park's Dr. Brian... |
| 10.07.2024 | The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care | LLS's Equity in Access Research Program Awards Four New Grants to Researchers Studying the Relationship Between Health Insurance and Access to Care and Interventions to Increase Therapeutic Clinical Trial Enrollment and Diversity
RYE BROOK,... |
| 21.06.2024 | FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park | Michael Ciesielski, PhD, left, and Robert Fenstermaker, MD, co-inventors of the SurVaxM cancer treatment vaccine, in their lab at Roswell Park Comprehensive Cancer Center.
The FDA has expanded orphan drug designation for SurVaxM, a brain ca... |
| 17.06.2024 | Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property | Complementary to Technology & IP Already Owned or In-Licensed;
Significant Step in Building a Leading Dendritic Cell Franchise
BETHESDA, Md., June 17, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a ... |
| 17.04.2024 | National Comprehensive Cancer Network Awards Champions for Excellence and Outstanding Contributions in Cancer Care | Dr. Shaji Kumar, Darcie Green, and members of the NCCN Covid-19 Vaccine Advisory Committee honored for their contributions to improving cancer care over the years; Donna Black named NCCN Employee of the Year.
PLYMOUTH MEETING, Pa., April 17... |
| 12.04.2024 | SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series | AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series
The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving patient outcomes by advancing the science and application ... |
| 08.04.2024 | Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients | Roswell Park Chair of Thoracic Surgery Dr. Sai Yendamuri will present his team’s latest findings on lung cancer and obesity during a major symposium at AACR 2024.
Obesity is associated with a higher risk of developing at least 13 types of c... |
| 03.04.2024 | E-Cigarette Users Are More Likely to End Traditional Smoking, Study Claims | Jace Dela Cruz, Tech Times 03 April 2024, 06:04 am
A recent study suggests that individuals who switch from traditional cigarettes to electronic cigarettes (e-cigarettes) are more inclined to end smoking combustible cigarettes, as reported ... |
| 22.03.2024 | Holiday Valley’s ‘UppenOvr’ raises $10,000 for Roswell Park | ELLICOTTVILLE — If success is measured in smiles, the UppenOvr uphill/downhill event March 16 at Holiday Valley was an overwhelming success.
The event was a fundraiser for Team Holiday Valley, which supports Roswell Park Comprehensive Cance... |
| 14.03.2024 | Health | New AI tools can record your medical appointment or draft a message from your doctor | By Carla K. Johnson, Associated Press
Don’t be surprised if your doctors start writing you overly friendly messages. They could be getting some help from artificial intelligence.
New AI tools are helping doctors communicate with their patie... |
| 07.03.2024 | Senior Experience Leaders Convene to Drive Healthcare Improvement | Representatives from 47 organizations join The Beryl Institute's 2024 Experience Leaders Circle
NASHVILLE, Tenn., March 7, 2024 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum ... |
| 04.06.2023 | Roswell Park Study May Provide Clues to Treating Colorectal Cancer More Effectively in Younger Patients | "This idea arose from my wanting to investigate the question of what factors at the metabolic level may be influencing the rise in young-onset colorectal cancer."
Chicago, IL (PRWEB) June 04, 2023
While the incidence of colorectal... |
| 21.02.2023 | Low Income Linked to High Recurrence Risk, Poorer Survival in Women With ER-Positive Breast Cancer | “We have known that income level increases the incidence of poor-prognosis triple-negative breast cancer,” notes Dr. Singh, “but this is the first data to show that income level impacts survival even in breast cancer with a better prognosis... |
| 02.12.2022 | Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment | Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment
Endpoints article | by Katherine Lewin
In a big week for Carrick Therapeutics, the company announced $60 million in funding for its lead breast cancer drug and dev... |
| 22.11.2022 | Health
Health | Grillo Center: Chemotherapy can cause peripheral neuropathy | By Sara Harper
Grillo Health Information Center
Q: I have peripheral neuropathy following chemotherapy. Is there anything I can do to alleviate my symptoms?
A: Chemotherapy-induced peripheral neuropathy is a set of symptoms caused by damage... |
| 02.11.2022 | Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse | We saw a 10% improvement in event-free survival — a real breakthrough. That’s quite a big gain, especially in pediatric Hodgkin lymphoma.
BUFFALO, N.Y., and ATLANTA, Ga. (PRWEB) November 02, 2022
— A targeted therapy for children with high-... |
| 01.11.2022 | Nation’s Top Cancer Organizations Partner to Endorse Initiative to Increase Lung Cancer Screening in the United States | Some of the 50-plus organizations that signed onto a consensus statement urging national action to get more people screened for lung cancer. We estimate as many as 60,000 lives could be saved each year if the 14.5 million Americans who are ... |
| 28.09.2022 | CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma | Dr. Renier Brentjens, Deputy Director at Roswell Park Comprehensive Cancer Center These results provide a rationale for not just infusing a single population of CAR T cells but using several populations that may be targeted to different pro... |
| 20.07.2022 | With hopes of paving new path for cancer treatment, Eli Lilly-backed Auron raises $48M | Auron Therapeutics has exited stealth mode with $48 million and backing from Big Pharma Eli Lilly, touting a new machine-learning platform and lofty hopes to flip the current cancer treatment paradigm on its head.
Lilly joins a roster of in... |
| 21.06.2022 | Indian cancer treatment firm raises $15m in series A round | NewsStartups
Jenina Ibañez · 21 Jun 2022 · 1 min readIndian cancer treatment firm raises $15m in series A round
Immuneel Therapeutics, an India-based biotech startup focused on cancer treatment, has raised US$15 million in a series A financ... |
| 06.06.2022 | Roswell Park Expert to Present on Effectiveness of New Combination for Acute Myeloid Leukemia | In a talk at ASCO 2022, Eunice Wang, MD, will present long-term results from a phase 2 trial of crenolanib with chemotherapy for treatment of adults with newly diagnosed FLT3-mutant AML. "Our results were highly promising, with more th... |
| 03.06.2022 | Roswell Park-Led Study: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma | Kara Kelly, MD, led research showing that brentuximab vedotin with standard chemotherapy is safe and effective as treatment for high-risk pediatric/adolescent Hodgkin lymphoma. “This study was the first to he first to establish that brentux... |
| 10.04.2022 | Roswell Park’s Dr. Grace Dy Presents Long-Term Data on CodeBreaK 100 Sotorasib Study | Roswell Park's Dr. Grace Dy is presenting findings from the international CodeBreaK 100 study of sotorasib for treatment of non-small cell lung cancer today at the AACR annual meeting. The results we’ve seen at two years show a pronounced b... |
| 09.04.2022 | Roswell Park Teams Look to Expand Immunotherapy Options for Patients with Advanced Breast and Colorectal Cancer | Drs. Shipra Gandhi, left, and Pawel Kalinski at Roswell Park are part of a team investigating ways to improve cancer immunotherapy. “We developed a systemic chemokine modulatory regimen that was effective in turning nonresponsive ‘cold’ tum... |
| 09.04.2022 | Roswell Park Explores Stress Receptors as Possible Immune Checkpoint, Suggesting Role for Beta-Blockers in Cancer Treatment | Roswell Park is exploring whether common blood pressure drugs can improve immunotherapy for cancer. "A provocative observed overall response rate of 78% suggests that this combination may be achieving a more meaningful anti-tumoral imm... |
| 06.04.2022 | New Immunotherapy Platform, Role of Stress in Cancer Highlight Roswell Park’s AACR 2022 Presentations | BUFFALO, N.Y. (PRWEB) April 06, 2022
Dozens of cancer specialists at Roswell Park Comprehensive Cancer Center have been invited to present their latest advances in cancer research at the annual meeting of the American Association for Cancer... |
| 23.03.2022 | Researchers Identify Gene That Predicts Breast Cancer Patients’ Treatment Outcomes | “It is amazing that we started with an agnostic search across the genome for genetic markers associated with breast cancer outcomes and identified UACA as a promising gene predictive of treatment outcomes for two commonly used agents for br... |
| 14.02.2022 | Roswell Park Sequencing Study Unlocks Mystery of Multiple Myeloma | “We discovered that myeloma cells show differences on a single-cell level in a single patient, both in different areas of the bone marrow and over time.”
BUFFALO, N.Y. (PRWEB) February 14, 2022
In 1873, Russian doctor J. von Rusitzky coined... |
| 03.02.2022 | Fungal Pathway Leads Roswell Park Researchers to New Treatment Target for Pancreatic Cancer | A team led by Prasenjit Dey, PhD, of Roswell Park has discovered a fungus-activated pathway that fuels growth of pancreatic cancer — and proposed a strategy for overcoming these processes. “This is one of the first studies to show the prese... |
| 11.12.2021 | Roswell Park Hematologists Present New Research on FLT3 Inhibitors, CART-19 at ASH Annual Meeting | The results of the study are likely to change the treatment paradigm for some patients with relapsed/refractory large B-cell lymphoma.
BUFFALO, N.Y. (PRWEB) December 11, 2021
Roswell Park Comprehensive Cancer Center hematology experts in le... |
| 04.11.2021 | Roswell Park Researchers Identify Key Link Between Stress and Cancer | Elizabeth Repasky, PhD, left, and Hemn Mohammadpour, PhD, DVM, from Roswell Park report new findings about the role certain immune cells play in affecting response to cancer treatment. This study provides some very important clues that help... |
| 26.10.2021 | Pancreatic Cancer Treatment Market valued at USD 4.2 billion by 2025 | Pancreatic Cancer Treatment Market valued at USD 4.2 billion by 2025
10-26-2021 07:23 AM CET | IT, New Media & Software
Press release from: Market Statsville Group
Pancreatic Cancer Treatment Market 2021-2027 Research Report provides... |
| 14.09.2021 | Roswell Park and University of Chicago Medicine Comprehensive Cancer Centers Awarded Nearly $9M for Ovarian Cancer Research | Drs. Kirsten Moysich and Kunle Odunsi are Multiple PIs on the SPORE grant. The projects we’re taking on focus on making immunotherapy, which has benefitted patients with many other cancer types, work better for patients with ovarian cancer ... |
| 24.08.2021 | Cellular Therapy Pioneer Renier Brentjens, MD, PhD, Joins Roswell Park as Deputy Director and Chair of Medicine | Renier Brentjens, MD, PhD, who helped develop a form of cancer treatment known as CAR T, joins Roswell Park as Deputy Director and Chair of Medicine. “Renier is both an amazing physician and a research star, and we couldn’t be more excited.... |
| 26.07.2021 | Roswell Park Experts Share Insights on Diagnosis and Treatment of Head & Neck Cancers at AHNS 2021 | Head/neck surgeon and cancer expert Vishal Gupta, MD, with a patient at Roswell Park. Our latest work presented at AHNS identifies several opportunities to apply next-generation insights, and we’re proud to help shape these conversations an... |
| 20.07.2021 | Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer | Fumito Ito, MD, PhD, and colleagues have shown that dendritic-cell treatment vaccines can be combined with radiation therapy as a potential treatment for some breast cancers. "We show that these approaches, radiotherapy and intratumora... |
| 02.07.2021 | Roswell Park Experts Highlight Opportunities to Improve Outcomes for People with Gastroesophageal Cancer | “Immune checkpoint inhibitors (ICI) have changed the landscape of cancer treatment in recent years, yet very few patients respond to this therapy,” notes Dr. Mukherjee. “So it is of utmost importance that we pursue the possibilities further... |
| 05.06.2021 | Roswell Park Team Demonstrates Safe Approach for Dramatically Reducing Use of Opioids Following Surgery | Roswell Park gynecologic oncologist Dr. Emese Zsiros, who developed and tested an approach for decreasing use of opioids and risk of chronic use among surgical patients. Our experience provides clear evidence that reducing the number of opi... |
| 04.06.2021 | Research From Roswell Park and Kaiser Permanente Supports Vitamin D Supplementation for Breast Cancer Patients | Drs. Song Yao, left, and Christine Ambrosone of Roswell Park's Cancer Prevention and Control program. Our findings from this large cohort of breast cancer survivors with long follow-up provide the strongest evidence to date for maintaining ... |
| 18.05.2021 | Dr. Elisa Rodriguez Named Roswell Park’s First-Ever Chief Diversity and Equity Officer for Faculty | Dr. Elisa Rodriguez has been named Roswell Park’s Chief Diversity and Equity Officer for Faculty. “Dr. Rodriguez is an outstanding researcher who has committed her career to overcoming health disparities, and will be an incredible asset and... |
| 18.05.2021 | Roswell Park Chief Pharmacy Officer Earns Career Honor from Professional Society | Dr. Leo Cai will receive the American Society of Health System Pharmacists’ Donald E. Francke Award for contributions to the field of clinical pharmacy. "Dr. Cai is a highly respected and accomplished leader in international pharmacy. ... |
| 12.05.2021 | Renowned Roswell Park Immunologist Promoted to Endowed Chair Role | Dr. Pawel Kalinski will now lead the Department of Immunology and the Division of Immuno-Oncology at Roswell Park. “The work Dr. Kalinski leads is stunning in its scope, its uniqueness and its potential for improving patient care and surviv... |
| 20.04.2021 | Roswell Park, Wilmot Cancer Institute Collaborate on First Large Study of Immunotherapy in Black Cancer Patients | Drs. Yao and Ambrosone are the Co-PI’s from Roswell Park. Checkpoint inhibitors have largely not been studied in Black cancer patients, but our recent findings show that there may be a particular benefit to these immunotherapies for cancer ... |
| 09.03.2021 | Cancer Patients Who Are Most Worried About Finances Shown to Have Worse Outcomes | “Doctors should consider how financial toxicity may be impacting their patients and do everything we can to improve our patients’ quality of life, and we want to encourage patients to take advantage of financial counseling and every other r... |
| 05.03.2021 | Why an abnormal Pap smear doesn’t always mean you have cancer | A Pap smear tests for abnormal cells in the cervix that may be cancerous or precancerous. Peter Dazeley/Getty Images
An abnormal Pap smear means some percentage of your cervix cells appear abnormal in shape or size.
In most cases, an abnorm... |
| 03.03.2021 | Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors | Dr. Fumito Ito and team's research on a new biomarker is published in the journal Nature Communications “This study sheds light on a promising blood-based biomarker that is potentially very useful in identifying which patients with lung can... |
| 17.02.2021 | Roswell Park Awarded Nearly $2 Million to Study Cause of Racial Disparities in Breast Cancer | Roswell Park epidemiologist Dr. Zhihong Gong Our study is novel and addresses an understudied area in breast cancer research among this underserved population with the worst prognosis.
BUFFALO, N.Y. (PRWEB) February 17, 2021
A research team... |
| 07.12.2020 | Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms | Next-generation tools are opening the window to a number of myeloma processes and defense mechanisms that we were not aware of just a few years ago.
BUFFALO, N.Y. (PRWEB) December 07, 2020
A group of researchers led by Maximillian Merz, MD,... |
| 07.12.2020 | Novel Therapy is Safe for Non-Hodgkin Lymphoma Patients, Roswell Park-Led Study Finds | Our data demonstrated that TRPH-222 was well-tolerated at the dose levels tested and very effective at disease control among patients with different subtypes of B-cell lymphoma.
BUFFALO, N.Y. (PRWEB) December 07, 2020
Roswell Park Comprehen... |
| 05.12.2020 | Roswell Park Leukemia Chief Shares Promising Findings on New Treatment Options at ASH 2020 | It’s encouraging to see signals of efficacy and evidence of good tolerability in these emerging treatment options, especially for subgroups of patients with AML whose cancers have been especially resistant to other therapies.
BUFFALO, N.Y. ... |
| 23.09.2020 | Precision cancer treatment company Novellus raises USD 57 million | Novellus, Ltd., a Jerusalem-based clinical-stage biotechnology company focused on precision oncology and cancer treatment, announced on Monday that it has raised USD 57 million in a Series C financing round.
The round was led by Israeli lif... |
| 08.07.2020 | Cancer treatment startup nabs $110M | Vor Biopharma has collected $110 million in Series B funding. RA Capital Management led the round, with support from new backers including Fidelity Management & Research, Pagliuca Family Office and Alexandria Venture Investments. Based ... |
| 26.05.2020 | Cancer treatment analytics startup raises $28M led by Baird Capital | Oncology Analytics, an Atlanta-based data-driven utilization management company with a focus on oncology, has raised $28 million in a Series C round led by Baird Capital. Existing investors Oak HC/FT, McKesson Ventures and The Blue Venture ... |
| 10.01.2020 | Tumor Board And Cancer Treatment Company OncoLens Closes $2.5 Million | Tumor board and cancer treatment planning software solutions company OncoLens announced it has raised $2.5 million in Series A funding
OncoLens — a pioneer in tumor board and cancer treatment planning software solutions — announced that it ... |
| 23.10.2019 | A million-dollar marketing juggernaut pushes 3D mammograms | “She said there’s a new approach and it’s much better, and it finds all cancer,” said McCaskill-Stevens, who declined the offer.
A short time later, a technician asked again: Was the patient sure she didn’t want 3D?
Upselling customers on h... |
| 22.08.2019 | This Polish biotech startup working on new breast cancer treatment secures €6.7M funding | Biotech is an industry that evolves constantly. There are several biotech startups that emerge from time to time. Leveraging modern technologies, these biotech startups reduce the treatment expenses in numerous ways. And, these companies al... |
| 23.01.2019 | Dog cancer treatment startup raises $5 million from Andreessen Horowitz and others | One in every three dogs gets cancer, according to the National Canine Cancer Foundation. The One Health Company, a startup that just raised a $5 million seed round led by Andreessen Horowitz’s Bio fund with participation from Lerer Hippeau ... |
| 27.09.2018 | New York cancer center launches 'historic' JV to bring Cuban-developed cancer drugs to US | Some of the next wave of immunotherapies designed to bolster checkpoint inhibitors will originate from Cuba — if Roswell Park Comprehensive Cancer Center’s latest venture flourishes according to plan.
Candace Johnson
... |
| 08.04.2015 | UK cancer treatment gets £100m boost with proton beam therapy centres in Cardiff, London and Northumberland | |
| 13.02.2015 | 10 Biggest Innovations in Health Care Technology in 2015 | referralMD | These miniature robots would function like their full-size equivalents with their own sensors, and propulsion systems and could perform small tasks like delivering chemotherapy 1000 times more powerful than using drugs and would not cause a... |
| 18.06.2014 | Biotech startup developing prostate cancer treatment is raising $7.5M | A research team led by Michael Ohlmeyer, an associate professor of structural and chemical biology at Mount Sinai, discovered a way to trigger the death of certain tumor cells. The team found that two tumor suppressor genes, KLF6 and FOXO1,... |
| 04.01.2013 | Skin cancer treatment device startup raises $2.4M for alternative to surgery | Traditionally, to treat nonmelanoma cancers, a procedure called Mohs surgery is performed, where the physician removes the tumor with a thin layer of tissue around it. Sensus says SRT doesn’t require anesthesia, is painless and avoids tissu... |
| 19.12.2012 | UVA spinoff using calcium channel blockers to improve cancer treatment gets $3M for trials | Tau is taking a bold move by hinging its lead product on mibefradil, which was formerly marketed by Roche for the treatment of hypertension. It was voluntarily withdrawn from the market in 1998 because of potentially harmful interactions wi... |
| 29.06.2011 | Skin cancer treatment startup in Minnesota raising $750,000 | Although RST Implanted Cell Technology has been around for more than five years, the focus on developing this product only began in the last year, he said. The company has developed a polymer technology and has filed appropriate patent appl... |
| 26.09.2006 | Cancer treatment co., NeoGuide, raises $25M | NeoGuide Systems, a Los Gatos developer of a colonoscopy system to help prevent and treat colorectal cancer, today said it has raised $25 million in a third round of financing.
NeoGuide’s technology is designed to enhance physician control ... |
| - | Pharmacy Times® Announces the Addition of Roswell Park Comprehensive Cancer Center to its Strategic Alliance Partnership Program | CRANBURY, N.J.--(BUSINESS WIRE)--Mar 22, 2021--
Pharmacy Times ®, the leading multimedia resource for pharmacy professionals, expands its Strategic Alliance Partnership (SAP) program with the addition of Roswell Park Comprehensive Cancer Ce... |
| - | UVA spinoff using calcium channel blockers to improve cancer treatment gets $3M for trials | A company repositioning drugs used to treat high blood pressure for use in improving chemotherapy has secured $3 million from investors to carry its lead candidate through Phase 1 trials.
Tau Therapeutics is repurposing the calcium channel ... |
| - | A million-dollar marketing juggernaut pushes 3D mammograms | When Dr. Worta McCaskill-Stevens made an appointment for a mammogram last year, she expected a simple breast cancer screening not a heavy-handed sales pitch.
A receptionist asked if she wanted a free upgrade to a “3D mammogram,” or tomosynt... |
| - | Biotech startup developing prostate cancer treatment is raising $7.5M | A biotechnology startup that spun out of University Hospitals of Cleveland last year has raised its first big round of financing since its launch two years ago. Dual Therapeutics, which is developing
therapeutics for prostate cancer, lung c... |
| - | Skin cancer treatment device startup raises $2.4M for alternative to surgery | A noninvasive device used to treat nonmelanoma skin cancers with radiation is getting a $2.4 million boost from investors as it makes its way into more oncology centers and dermatology offices across the world.
In a recent U.S. Securities a... |
| - | Skin cancer treatment startup in Minnesota raising $750,000 | A St. Paul, Minnesota startup is looking to raise $750,000 to develop a drug/device combination for certain types of skin cancer.
A recent regulatory filing with the U.S. Securities and Exchange Commission shows that RST Implanted Cell Tech... |
| - | 10 Biggest Innovations in Health Care Technology in 2015 | referralMD | A new year is upon us and we are already seeing amazing advancements in healthcare technology, everything from enterprise cloud software to nanobots. Is healthcare finally catching up with the times?
New startups and fortune 500 companies a... |
